1118 related articles for article (PubMed ID: 12698094)
1. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
6. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
9. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
10. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
11. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
[TBL] [Abstract][Full Text] [Related]
12. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
15. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
16. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
17. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against MICA antigens and kidney-transplant rejection.
Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
[TBL] [Abstract][Full Text] [Related]
19. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
20. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
